Likes Receivedhttps://www.exscientia.com
Even more, we don't want $Recursion Pharmaceuticals(RXRX.US) to rise now.
Recursion Pharmaceuticals granted 7,952,836 RSU awards to 230 new employees, per Nasdaq rules, in connection with an acquisition.
Recursion Pharmaceuticals, Inc. has granted 7,952,836 restricted stock units (RSUs) to 230 new employees as part of its acquisition of Exscientia plc. This allocation was approved by the Compensation Committee of the Board of Directors on December 19, 2024, under the 2024 Inducement Equity Incentive Plan, in compliance with Nasdaq Listing Rule 5635(c)(4).
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
